Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Health Care, Big Data. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Twist Bioscience, WuXi NextCODE.
The important activity for fund was in 2017. The increased amount of exits for fund were in 2018. Opposing the other organizations, this 3W Partners works on 38 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 50 - 100 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the 3W Partners, startups are often financed by Asset Management Ventures (AMV), ARCH Venture Partners, Paladin Capital Group. The meaningful sponsors for the fund in investment in the same round are YF Capital (Yunfeng Capital), Temasek Holdings, Sequoia Capital. In the next rounds fund is usually obtained by YF Capital (Yunfeng Capital), Temasek Holdings, Sequoia Capital.
Related Funds
Funds with similar focus
Fund Name | Location |
Assets New Ventures | - |
Blue Ocean Capital Group | China, Guangdong, Shenzhen |
Blue Wave Innovation Capital | County Dublin, Dublin, Ireland |
Davidson consulting | Boulogne-Billancourt, France, Ile-de-France |
Emergent Game Technologies | Calabasas, California, United States |
Estrella Roja | - |
GNI Group | - |
Invitalia | Italy, Lazio, Roma |
JNS HOLDINGS | Japan, Tokyo |
JSW Ventures | India, Maharashtra, Mumbai |
Mintian Capital | - |
Omega Funds | Boston, Massachusetts, United States |
Oscar Health | New York, New York, United States |
Platform Investment Partners | Gauteng, Johannesburg, South Africa |
SAINT-CARE HOLDINGS | Japan, Tokyo |
WS Ventures Management | Dallas, Texas, United States |
Yanlingxian Qianqian Shangmao | China, Henan, Henan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
LifeMine Therapeutics | $175M | 23 Mar 2022 | Cambridge, Massachusetts, United States | ||
Beijing Tianxing | 01 Jan 2022 | Daxing, Beijing, China | |||
Jiadianziwei | $15M | 04 Nov 2021 | Hangzhou, Zhejiang, China | ||
Steadiwear | $874K | 26 Jul 2021 | Old Toronto, Ontario, Canada | ||
$165M | 05 Sep 2017 | Boston, Massachusetts, United States | |||
Genuity Science | $75M | 02 May 2017 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
LifeMine Therapeutics | $175M | 23 Mar 2022 | Cambridge, Massachusetts, United States | ||
Beijing Tianxing | 01 Jan 2022 | Daxing, Beijing, China | |||
Jiadianziwei | $15M | 04 Nov 2021 | Hangzhou, Zhejiang, China | ||
Steadiwear | $874K | 26 Jul 2021 | Old Toronto, Ontario, Canada | ||
$165M | 05 Sep 2017 | Boston, Massachusetts, United States | |||
Genuity Science | $75M | 02 May 2017 | Boston, Massachusetts, United States |